HCV targeting of patients with cirrhosis

Slides:

Advertisements

Similar presentations

EASL Clinical Practice Guidelines: Vascular diseases of the liver Journal of Hepatology Volume 64, Issue 1, Pages (January 2016) DOI: /j.jhep

Advertisements

Omega 3 – Omega 6: What is right for the liver? Ashraf Mohammad El-Badry, Rolf Graf, Pierre-Alain Clavien Journal of Hepatology Volume 47, Issue 5, Pages.

Volume 63, Issue 1, Pages (July 2015)

Volume 46, Issue 3, Pages (March 2007)

The impact of hepatitis E in the liver transplant setting

Kirsten Boonstra, Ulrich Beuers, Cyriel Y. Ponsioen

Inflammasomes in liver diseases

Volume 61, Issue 4, Pages (October 2014)

Lifestyle interventions for the treatment of non-alcoholic fatty liver disease in adults: A systematic review Christian Thoma, Christopher P. Day, Michael.

Which patients with genotype 1 chronic hepatitis C can benefit from prolonged treatment with the ‘accordion’ regimen? Patrick Marcellin, E. Jenny Heathcote,

Volume 68, Issue 5, Pages (May 2018)

Primary prevention of variceal haemorrhage: A pharmacological approach

Julien Bissonnette, Dominique Valla, Pierre-Emmanuel Rautou

Volume 61, Issue 6, Pages (December 2014)

Halis Simsek, Ali Shorbagi, Yasemin Balaban, Gonca Tatar

Volume 51, Issue 6, Pages (December 2009)

The impact of hepatitis E in the liver transplant setting

Reactive oxygen species in the normal and acutely injured liver

Cédric Coulouarn, Bruno Clément Journal of Hepatology

Matthew T. Kitson, Stuart K. Roberts Journal of Hepatology

NS5A inhibitors in the treatment of hepatitis C

Immigration and viral hepatitis

Marcus-Alexander Wörns, Peter Robert Galle Journal of Hepatology

Individualized prediction of hepatocellular carcinoma occurrence in a large cohort of patients with cirrhosis Astrid Marot, Jean Henrion, Jean-François.

Volume 66, Issue 1, Pages 1-4 (January 2017)

The evidence supports a viral aetiology for primary biliary cirrhosis

Living donor liver transplantation: is the hype over?

Volume 69, Issue 2, Pages (August 2018)

Volume 44, Pages S19-S24 (January 2006)

The place of downstaging for hepatocellular carcinoma

Volume 58, Issue 3, Pages (March 2013)

Reply to: “Low free T3 levels are related to early mortality in patients with decompensated cirrhosis and acute-on chronic liver failure” Rakhi Maiwall,

Autoimmune hepatitis: A life-long disease

Jordan J. Feld, Graham R. Foster Journal of Hepatology

Cheng-Yuan Peng, Rong-Nan Chien, Yun-Fan Liaw Journal of Hepatology

Volume 65, Issue 4, Pages (October 2016)

European Association for the Study of the Liver Journal of Hepatology

Hepatitis C core protein – The “core” of immune deception?

Volume 61, Issue 1, Pages S108-S119 (November 2014)

Statin use and the risk of hepatocellular carcinoma in patients at high risk: A nationwide nested case-control study Gyuri Kim, Suk-Yong Jang, Chung.

Volume 61, Issue 1, Pages S69-S78 (November 2014)

Volume 62, Issue 3, Pages (March 2015)

Acute hepatitis C: Current status and remaining challenges

Darius Moradpour, Arash Grakoui, Michael P. Manns

Behzad Hajarizadeh, Jason Grebely, Gregory J. Dore

EASL Clinical Practice Guidelines: Wilson’s disease

Roberto de Franchis, Aleksander Krag Journal of Hepatology

Volume 61, Issue 1, Pages S45-S57 (November 2014)

The changing role of beta-blocker therapy in patients with cirrhosis

Volume 57, Issue 5, Pages (November 2012)

Cédric Coulouarn, Bruno Clément Journal of Hepatology

Antiviral therapy for chronic hepatitis B: Challenges in Hong Kong

Paul C. Adams, James C. Barton Journal of Hepatology

Immigration and viral hepatitis

Global burden of alcoholic liver diseases

Volume 63, Issue 1, Pages (July 2015)

Familial amyloidosis: Great progress for an orphan disease

Chronic hepatitis B in children and adolescents

Hepatorenal syndrome, MELD score and liver transplantation: An evolving issue with relevant implications for clinical practice Paolo Angeli, Pere Gines

New trials and results in systemic treatment of HCC

Liver transplantation in children

Ana Lleo, M. Eric Gershwin, Alberto Mantovani, Pietro Invernizzi

Volume 60, Issue 6, Pages (June 2014)

Reply to: “Flow cytometry makes all the difference”

Pathogenesis of cholestatic hepatitis C

Chimeric mouse model of hepatitis B virus infection

Elisabeth Eder, Thomas-Matthias Scherzer, Harald Hofer, Peter Ferenci

Volume 54, Issue 6, Pages (June 2011)

Reversion of disease manifestations after HCV eradication

Volume 60, Issue 6, Pages (June 2014)

Presentation transcript:

HCV targeting of patients with cirrhosis Peter Ferenci, Karin Kozbial, Mattias Mandorfer, Harald Hofer Journal of Hepatology Volume 63, Issue 4, Pages 1015-1022 (October 2015) DOI: 10.1016/j.jhep.2015.06.003 Copyright © 2015 European Association for the Study of the Liver Terms and Conditions

Fig. 1 A tentative response guided algorithm to select the optimal treatment duration in patients with cirrhosis (based on data from Kozbial et al. [69]). TND, target not detected by ART. Journal of Hepatology 2015 63, 1015-1022DOI: (10.1016/j.jhep.2015.06.003) Copyright © 2015 European Association for the Study of the Liver Terms and Conditions

Journal of Hepatology 2015 63, 1015-1022DOI: (10. 1016/j. jhep. 2015 Copyright © 2015 European Association for the Study of the Liver Terms and Conditions